生长激素治疗障碍评估量表的汉化及信效度检验

打开文本图片集

基金项目 2023年度湖南省自然科学基金项目，编号：2023JJ60047

作者简介 王灵，主管护师，硕士

* 通讯作者 王志敏，E-mail：153462814@qq.com

引用信息 王灵，王志敏，彭艳红，等.生长激素治疗障碍评估量表的汉化及信效度检验［J］.循证护理，2025，11（1）：37-42.

Abstract Objective：To localize the Barriers to Growth Hormone treatment（BAR⁃GHT）and test its reliability and validity in patients with dwarfism.Methods：Through translation，back⁃translation，cultural adjustment，and pre⁃experiment，the Chinese version of BAR⁃GHT was formed.A total of 216 patients with dwarfism who had received growth hormone treatment for more than 3 months and their parents were selected for the questionnaire survey to verify its reliability and validity.Results：The Chinese version of BAR⁃GHT included a parent version（16 items in 5 dimensions）and a child/adolescent version（17 items in 5 dimensions）.The Cronbach's α coefficients of the scales were 0.876 and 0.905，the split⁃half reliability was 0.852 and 0.793，and the test⁃retest reliability was 0.857 and 0.934，respectively.The scale⁃level content validity index was 0.921 and 0.933，and the criterion⁃correlated validity with the 8⁃item Morisky Medication Adherence Scale was 0.597 and 0.703（all P<0.01），respectively.Exploratory factor analysis extracted 5 common factors，and the cumulative variance contribution rates were 82.442%and 81.433%，respectively.Conclusions：The Chinese version of BAR⁃GHT has good reliability and validity，which can be used to assess the level of growth hormone treatment barriers among patients with dwarfism in China.

Keywords  growth hormone；treatment barriers；scale；dwarfism；reliability；validity

摘要  目的：汉化生长激素治疗障碍评估量表（BAR⁃GHT），并检验其在矮小症病人中的信效度。（剩余10764字）